Skip to main content

Abstract 340: Myocyte-borne Bdnf is Essential to Limit Post-ischemic Cardiac Injury and Dysfunction

Publication ,  Conference
Jun, S; Agrimi, J; Cannavo, A; Keceli, G; Oeing, CU; Eremiev, A; Marcucci, L; Megighian, A; RENGO, G; Koch, WJ; Paolocci, N
Published in: Circulation Research
July 31, 2020

(BDNF)/ (TrkB) signaling is essential for normal cardiac contraction/relaxation. Alterations in this pathway, i.e., defective neuronal BDNF, account for post-ischemic cardiac injury. Less clear, however, is whether myocyte-borne BDNF has a role in this setting. We generated myocyte-selective BDNF knock-out (myoBDNF ) mice, using Myh6-Cre mice crossed with BDNF mice, confirming deletion via RT-PCR in isolated myocytes. Hearts from 12-wk old myoBDNF mice and WT littermates underwent global ischemia (30 min) and reperfusion (2 h). At this age, the two strains had similar left ventricular (LV) sizes and fractional shortening [63±1.1 (WT) 60±1.2% (myoBDNF )]. At reperfusion, myoBDNF hearts displayed larger infarct size compared to WT (38±3 14±2%, n=9, p<.0001) and worsened LV functional recovery ( ). For example, the rate-pressure product recuperated only by 14±1.5 in myoBDNF mice 36±3% in WT (p<.0001). The two groups had similar heart rates at 2 h reperfusion, however myoBDNF mice markedly lost their contractility [dP/dt = 436±58 1407±142 mmHg/sec (WT), p< .0001], likely due to the exacerbated myocyte loss. Accordingly, post-ischemic troponin I release was significantly higher in myoBDNF than in WT mice (0.9±0.04 1.3±0.04 ng/ml, p<.0002). Thus, deleting in myocytes severely limits recovery after ischemia, directly linking myocyte-borne BDNF to the heart response to injury. Therefore, preserving or enhancing autologous myocyte BDNF generation offers new avenues to counter cardiac ischemic injury and subsequent heart failure progression.

Duke Scholars

Published In

Circulation Research

DOI

EISSN

1524-4571

ISSN

0009-7330

Publication Date

July 31, 2020

Volume

127

Issue

Suppl_1

Publisher

Ovid Technologies (Wolters Kluwer Health)

Related Subject Headings

  • Cardiovascular System & Hematology
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Jun, S., Agrimi, J., Cannavo, A., Keceli, G., Oeing, C. U., Eremiev, A., … Paolocci, N. (2020). Abstract 340: Myocyte-borne Bdnf is Essential to Limit Post-ischemic Cardiac Injury and Dysfunction. In Circulation Research (Vol. 127). Ovid Technologies (Wolters Kluwer Health). https://doi.org/10.1161/res.127.suppl_1.340
Jun, Seungho, Jacopo Agrimi, Alessandro Cannavo, Gizem Keceli, Christian U. Oeing, Alexander Eremiev, Lorenzo Marcucci, et al. “Abstract 340: Myocyte-borne Bdnf is Essential to Limit Post-ischemic Cardiac Injury and Dysfunction.” In Circulation Research, Vol. 127. Ovid Technologies (Wolters Kluwer Health), 2020. https://doi.org/10.1161/res.127.suppl_1.340.
Jun S, Agrimi J, Cannavo A, Keceli G, Oeing CU, Eremiev A, et al. Abstract 340: Myocyte-borne Bdnf is Essential to Limit Post-ischemic Cardiac Injury and Dysfunction. In: Circulation Research. Ovid Technologies (Wolters Kluwer Health); 2020.
Jun, Seungho, et al. “Abstract 340: Myocyte-borne Bdnf is Essential to Limit Post-ischemic Cardiac Injury and Dysfunction.” Circulation Research, vol. 127, no. Suppl_1, Ovid Technologies (Wolters Kluwer Health), 2020. Crossref, doi:10.1161/res.127.suppl_1.340.
Jun S, Agrimi J, Cannavo A, Keceli G, Oeing CU, Eremiev A, Marcucci L, Megighian A, RENGO G, Koch WJ, Paolocci N. Abstract 340: Myocyte-borne Bdnf is Essential to Limit Post-ischemic Cardiac Injury and Dysfunction. Circulation Research. Ovid Technologies (Wolters Kluwer Health); 2020.

Published In

Circulation Research

DOI

EISSN

1524-4571

ISSN

0009-7330

Publication Date

July 31, 2020

Volume

127

Issue

Suppl_1

Publisher

Ovid Technologies (Wolters Kluwer Health)

Related Subject Headings

  • Cardiovascular System & Hematology
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology